158 related articles for article (PubMed ID: 11950095)
1. Relationship between mTHPC fluorescence photobleaching and cell viability during in vitro photodynamic treatment of DP16 cells.
Dysart JS; Patterson MS; Farrell TJ; Singh G
Photochem Photobiol; 2002 Mar; 75(3):289-95. PubMed ID: 11950095
[TBL] [Abstract][Full Text] [Related]
2. Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells.
Dysart JS; Singh G; Patterson MS
Photochem Photobiol; 2005; 81(1):196-205. PubMed ID: 15469385
[TBL] [Abstract][Full Text] [Related]
3. Influence of incubation time and sensitizer localization on meta-tetra(hydroxyphenyl)chlorin (mTHPC)-induced photoinactivation of cells.
Sasnouski S; Pic E; Dumas D; Zorin V; D'Hallewin MA; Guillemin F; Bezdetnaya L
Radiat Res; 2007 Aug; 168(2):209-17. PubMed ID: 17638401
[TBL] [Abstract][Full Text] [Related]
4. Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice.
Coutier S; Bezdetnaya LN; Foster TH; Parache RM; Guillemin F
Radiat Res; 2002 Sep; 158(3):339-45. PubMed ID: 12175311
[TBL] [Abstract][Full Text] [Related]
5. In vivo mTHPC photobleaching in normal rat skin exhibits unique irradiance-dependent features.
Finlay JC; Mitra S; Foster TH
Photochem Photobiol; 2002 Mar; 75(3):282-8. PubMed ID: 11950094
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic properties of meta-tetra(hydroxyphenyl)chlorin in human tumor cells.
Melnikova VO; Bezdetnaya LN; Potapenko AY; Guillemin F
Radiat Res; 1999 Oct; 152(4):428-35. PubMed ID: 10477920
[TBL] [Abstract][Full Text] [Related]
7. Effects of fluence rate on cell survival and photobleaching in meta-tetra-(hydroxyphenyl)chlorin-photosensitized Colo 26 multicell tumor spheroids.
Coutier S; Mitra S; Bezdetnaya LN; Parache RM; Georgakoudi I; Foster TH; Guillemin F
Photochem Photobiol; 2001 Mar; 73(3):297-303. PubMed ID: 11281027
[TBL] [Abstract][Full Text] [Related]
8. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
9. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements.
Glanzmann T; Forrer M; Blant SA; Woodtli A; Grosjean P; Braichotte D; van den Bergh H; Monnier P; Wagnières G
J Photochem Photobiol B; 2000 Aug; 57(1):22-32. PubMed ID: 11100834
[TBL] [Abstract][Full Text] [Related]
11. Monitoring interstitial m-THPC-PDT in vivo using fluorescence and reflectance spectroscopy.
Kruijt B; van der Ploeg-van den Heuvel A; de Bruijn HS; Sterenborg HJ; Amelink A; Robinson DJ
Lasers Surg Med; 2009 Nov; 41(9):653-64. PubMed ID: 19802884
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic effects of mTHPC on human colon adenocarcinoma cells: photocytotoxicity, subcellular localization and apoptosis.
Leung WN; Sun X; Mak NK; Yow CM
Photochem Photobiol; 2002 Apr; 75(4):406-11. PubMed ID: 12003131
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic mechanisms induced by a combination of hypericin and a chlorin based-photosensitizer in head and neck squamous cell carcinoma cells.
Gyenge EB; Lüscher D; Forny P; Antoniol M; Geisberger G; Walt H; Patzke G; Maake C
Photochem Photobiol; 2013; 89(1):150-62. PubMed ID: 22882495
[TBL] [Abstract][Full Text] [Related]
14. Activation of heat shock protein 70 promoter with meso-tetrahydroxyphenyl chlorin photodynamic therapy reported by green fluorescent protein in vitro and in vivo.
Mitra S; Goren EM; Frelinger JG; Foster TH
Photochem Photobiol; 2003 Dec; 78(6):615-22. PubMed ID: 14743872
[TBL] [Abstract][Full Text] [Related]
15. Comparative sensitivity of microvascular endothelial cells, fibroblasts and tumor cells after in vitro photodynamic therapy with meso-tetra-hydroxyphenyl-chlorin.
Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
Photochem Photobiol; 2004; 80(2):236-41. PubMed ID: 15362947
[TBL] [Abstract][Full Text] [Related]
16. Effect of meta-tetra(hydroxyphenyl)chlorin (mTHPC)-mediated photodynamic therapy on sensitive and multidrug-resistant human breast cancer cells.
Teiten MH; Bezdetnaya L; Merlin JL; Bour-Dill C; Pauly ME; Dicato M; Guillemin F
J Photochem Photobiol B; 2001 Sep; 62(3):146-52. PubMed ID: 11566278
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers.
Ma L; Moan J; Berg K
Int J Cancer; 1994 Jun; 57(6):883-8. PubMed ID: 8206681
[TBL] [Abstract][Full Text] [Related]
18. Inclusion complexation with β-cyclodextrin derivatives alters photodynamic activity and biodistribution of meta-tetra(hydroxyphenyl)chlorin.
Yankovsky I; Bastien E; Yakavets I; Khludeyev I; Lassalle HP; Gräfe S; Bezdetnaya L; Zorin V
Eur J Pharm Sci; 2016 Aug; 91():172-82. PubMed ID: 27320407
[TBL] [Abstract][Full Text] [Related]
19. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response.
Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792
[TBL] [Abstract][Full Text] [Related]
20. Foscan (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-alpha-mediated cytolytic activity.
Coutier S; Bezdetnaya L; Marchal S; Melnikova V; Belitchenko I; Merlin JL; Guillemin F
Br J Cancer; 1999 Sep; 81(1):37-42. PubMed ID: 10487610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
